Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Aug 2023, 17:18:25 UTC
Prior SEC filing
02 Aug 2023
Next SEC filing
15 Sep 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Scott Ring, General Counsel, Deer IX & Co. Ltd., the General Partner of Deer IX I & Co. L.P., the General Partner of Bessemer Venture Partners IX L.P.

Key filing fact

Bessemer Venture Partners IX L.P. filed Form 4 for Weave Communications, Inc. (WEAV) on 04 Aug 2023.

Key facts

  • This page summarizes Bessemer Venture Partners IX L.P.'s Form 4 filing for Weave Communications, Inc. (WEAV).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Aug 2023, 17:18.

Change

  • Previous filing in this sequence was filed on 02 Aug 2023.
  • Current net transaction value: -$661,791.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WEAV transaction

Common Stock

Sale

Transaction value
$631,044
Shares
-56,444
Change %
-0.78%
Price
$11.18
Shares after
7,140,474
Date
03 Aug 2023
Ownership
See Footnotes
Footnotes
F1, F2, F3
WEAV transaction

Common Stock

Sale

Transaction value
$30,747
Shares
-2,775
Change %
-0.04%
Price
$11.08
Shares after
7,137,699
Date
04 Aug 2023
Ownership
See Footnotes
Footnotes
F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

On August 3, 2023, Bessemer Venture Partners IX L.P. ("BVP IX") and Bessemer Venture Partners IX Institutional L.P. ("BVP IX Inst" and together with BVP IX the "BVP IX Funds") sold 31,338 shares and 25,106 shares of Common Stock of Weave Communications, Inc., respectively, at a weighted average price of $11.18. These shares were sold in multiple transactions at prices ranging from $11.00 to $12.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F2

After the August 3 sales, BVP IX and BVP IX Inst own 3,964,392 shares of Common Stock and 3,176,082 of Common Stock, respectively.

Footnote F3

Deer IX & Co. Ltd. ("Deer Ltd.") is the general partner of Deer IX & Co. L.P. ("Deer L.P."), which is the general partner of each of the Funds. Deer Ltd. and Deer L.P. disclaim beneficial ownership of the securities held by the BVP IX Funds, and this report shall not be deemed an admission that Deer Ltd. and Deer L.P. are the beneficial owners of such securities, except to the extent of their pecuniary interest therein, if any, by virtue of their direct and indirect general partner interests in the BVP IX Funds.

Footnote F4

On August 4, 2023, BVP IX and BVP IX Inst sold 1,541 shares and 1,234 shares of Common Stock of Weave Communications, Inc., respectively, at a weighted average price of $11.08. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F5

As the date hear of, BVP IX and BVP IX Inst own 3,962,851 shares of Common Stock and 3,174,848 of Common Stock, respectively.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .